Knowledge of the mechanisms underlying the normal development of blood cells will lead to new understanding and treatments of various blood diseases, including leukemias. The long range goals are to further our understanding of the mechanisms involved in myelopoiesis and leukemia by understanding the transcription factors which regulate myeloid development from stem cells. The transcription factor CCAAT Enhancer Binding Protein alpha (C/EBP alpha) is required for differentiation of normal myeloid blasts and disrupted through multiple mechanisms in Acute Myeloid Leukemia (AML). Conditional knockout models demonstrate that loss of C/EBP alpha leads to increased self-renewal and repopulating ability of fetal liver hematopoietic stem cells (HSC), as well as a block in differentiation at a distinct stage of granulocytic differentiation. Over the next 5 years, we propose to extend the study of this critical transcription factor in hematopoietic stem cells. We therefore propose the following Specific Aims: (1) What is the role of C/EBP alpha with respect to numbers and function of adult HSC? (2) What is the role of cytokines on C/EBP family member expression and granulopoiesis? (3) How does C/EBPa regulate Bmi-1 and affect HSC function? These studies will lead to new insights into the role of this transcription factor in HSC and progenitor function, which is relevant to the understanding of normal hematopoietic differentiation and leukemogenesis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL056745-14
Application #
7766962
Study Section
Hematopoiesis Study Section (HP)
Program Officer
Welniak, Lisbeth A
Project Start
1996-08-01
Project End
2012-01-31
Budget Start
2010-02-01
Budget End
2012-01-31
Support Year
14
Fiscal Year
2010
Total Cost
$412,816
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02215
Ye, Min; Zhang, Hong; Amabile, Giovanni et al. (2013) C/EBPa controls acquisition and maintenance of adult haematopoietic stem cell quiescence. Nat Cell Biol 15:385-94
Welner, Robert S; Bararia, Deepak; Amabile, Giovanni et al. (2013) C/EBP? is required for development of dendritic cell progenitors. Blood 121:4073-81
Di Ruscio, Annalisa; Ebralidze, Alexander K; Benoukraf, Touati et al. (2013) DNMT1-interacting RNAs block gene-specific DNA methylation. Nature 503:371-6
Yong, Kol Jia; Gao, Chong; Lim, Joline S J et al. (2013) Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. N Engl J Med 368:2266-76
Zhang, Hong; Alberich-Jorda, Meritxell; Amabile, Giovanni et al. (2013) Sox4 is a key oncogenic target in C/EBP? mutant acute myeloid leukemia. Cancer Cell 24:575-88
Chen, Leilei; Li, Yan; Lin, Chi Ho et al. (2013) Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma. Nat Med 19:209-16
Alberich-Jordà, Meritxell; Wouters, Bas; Balastik, Martin et al. (2012) C/EBP? deregulation results in differentiation arrest in acute myeloid leukemia. J Clin Invest 122:4490-504
Jiang, Shuxian; Alberich-Jorda, Meritxell; Zagozdzon, Radoslaw et al. (2011) Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization. Blood 117:827-38
Blanchet, Marie-Renee; Bennett, Jami L; Gold, Matthew J et al. (2011) CD34 is required for dendritic cell trafficking and pathology in murine hypersensitivity pneumonitis. Am J Respir Crit Care Med 184:687-98
Grandinetti, K B; Stevens, T A; Ha, S et al. (2011) Overexpression of TRIB2 in human lung cancers contributes to tumorigenesis through downregulation of C/EBP?. Oncogene 30:3328-35

Showing the most recent 10 out of 30 publications